• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    Impax Laboratories Inc. (IPXL)

    -NasdaqGS
    29.26 Down 1.07(3.53%) Jun 24, 4:00PM EDT
    |After Hours : 29.25 Down 0.01 (0.02%) Jun 24, 5:19PM EDT
    Prev Close:30.33
    Open:28.85
    Bid:N/A
    Ask:35.87 x 200
    1y Target Est:36.62
    Beta:1.18704
    Earnings Date:Aug 8 - Aug 12 (Est.)
    Day's Range:28.85 - 29.87
    52wk Range:27.62 - 51.42
    Volume:954,857
    Avg Vol (3m):659,017
    Market Cap:2.16B
    P/E (ttm):61.47
    EPS (ttm):0.48
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IPXLDown 3.53%2.16B
    MYLDown 5.63%22.14B

    Key Statistics

    Forward P/E (1 yr):11.80
    P/S (ttm):2.28
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :1.76
    Quarterly EPS Est (Jun-16) :0.34
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.64

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products. It operates in two segments, Impax Generics and Impax Specialty Pharma. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback